Valuation: Nipro Corporation

Market Cap 240B 1.51B 1.33B 1.25B 1.14B 2.13B 145B 2.15B 14.99B 5.81B 73.6B 5.66B 5.53B P/E 2027 *
14.9x
P/E 2028 * 11.3x
Enterprise Value 740B 4.66B 4.1B 3.86B 3.52B 6.59B 447B 6.64B 46.34B 17.96B 228B 17.49B 17.11B EV / Sales 2027 *
1.06x
EV / Sales 2028 * 1x
Free-Float
85.55%
Yield 2027 *
2.5%
Yield 2028 * 3.12%
1 day+2.79%
Current month+21.02%
Current year+21.02%
3 years 8.23
Extreme 8.23
9.96
5 years 8.23
Extreme 8.23
9.96
10 years 8.23
Extreme 8.23
9.96
Manager TitleAgeSince
Director of Finance/CFO 57 01/06/2025
President 58 01/06/2025
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 81 26/06/2025
Director/Board Member 53 01/06/2009
Director/Board Member 58 01/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
+2.79%-.--% - - 1.51B
-2.34%-1.13%-24.51%+2.98% 179B
-0.88%-4.59%-7.55%+10.27% 114B
-0.77%+0.15%+0.49%+66.64% 59.59B
-1.80%-1.19%-3.67%-32.42% 49.72B
+1.51%+3.98%+13.83%+52.43% 47.75B
-0.30%-0.52%+29.59%-0.03% 33.11B
+1.05%+7.91% - - 30.09B
-0.60%+1.91%+43.73%+0.29% 26.45B
+4.96%+10.05%+19.03%-6.09% 22.79B
Average +0.37%+1.57%+8.87%+11.76% 62.53B
Weighted average by Cap. -0.81%-0.43%-4.08%+12.08%

Financials

2027 *2028 *
Net sales 701B 4.41B 3.88B 3.66B 3.34B 6.24B 423B 6.29B 43.88B 17B 215B 16.56B 16.2B 729B 4.58B 4.03B 3.8B 3.47B 6.49B 440B 6.54B 45.62B 17.68B 224B 17.21B 16.84B
Net income 15.39B 96.83M 85.17M 80.29M 73.25M 137M 9.29B 138M 963M 373M 4.73B 364M 356M 19.95B 126M 110M 104M 94.95M 178M 12.05B 179M 1.25B 484M 6.13B 471M 461M
Net Debt 501B 3.15B 2.77B 2.61B 2.38B 4.46B 302B 4.49B 31.35B 12.15B 154B 11.83B 11.57B 489B 3.08B 2.71B 2.55B 2.33B 4.35B 295B 4.39B 30.62B 11.87B 150B 11.55B 11.3B
Logo Nipro Corporation
Nipro Corp is a Japan-based company mainly engaged in the medical, pharmaceutical, and pharma packaging businesses. It has three segments. The Medical segment consists of the domestic business division and the international business division. The domestic business division sells medical devices related to injections and infusions, artificial organs, high-performance medicines, and dialysis. The international business division, centered on the head office, has medical device manufacturing and sales bases overseas for regional expansion, selling medical devices related to injections and infusions, artificial organs, and diabetes. The Pharmaceutical segment sells pharmaceuticals related to kit preparation containers on a contract basis from pharmaceutical companies. The Pharma Packaging segment sells medical glass products such as glass tubes and ampoules, thermos flasks, and kit preparation containers in Japan.
Employees
38,593
Date Price Change
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
1,441.00JPY
Average target price
1,996.00JPY
Spread / Average Target
+38.51%

Quarterly revenue - Rate of surprise